期刊文献+

埃索美拉唑根除HP感染消化性溃疡疗效观察 被引量:4

Therapeutic Effects of Esomeprazole on Peptic Ulcer Caused by Helicobacter Pylori Infection
原文传递
导出
摘要 目的观察埃索美拉唑三联疗法根除幽门螺旋杆菌(Helieobacter pylori,HP)感染消化性溃疡(Peptic Ulcer,PU)的临床疗效。方法将100例HP感染消化性溃疡按随机数字表法分为治疗组(埃索美拉唑+克拉霉素+阿莫西林)50例和对照组(奥美拉唑+克拉霉素+阿莫西林)50例,治疗1个疗程后,观察患者溃疡愈合和HP根除情况。结果与对照组比较,治疗组愈合率、总有效率明显高于对照组(P<0.05);治疗组HP根除率差异无统计学意义(P>0.05),但治疗组HP根除率高于对照组。结论以埃索美拉唑+克拉霉素+阿莫西林三联疗法在治疗消化性溃疡的愈合率、有效率方面明显优于奥美拉唑+克拉霉素+阿莫西林三联疗法,HP根除率高于奥美拉唑三联疗法,值得临床推广。 Objective To investigate the clinical effects of esomeprazole combined therapy in radical treatment of peptic ulcer (PU) caused by Helicobacter pylori (HP). Methods 100 eases of peptic ulcer patients with HP infection were randomly divided into treatment groups(50 cases, treated by esomeprazole + clarithromycin + amoxicillin) and control group (50 cases, treated by omeprazole + clarithromycin + amoxicillin). After a course of treatment ,The healing of ulcer and eradication rate of Hp were ob- served. Results The healing rate and total effective rate of the treatment group was significantly higher than that of the control group ( P 〈 0. 05 ). There was no statistical difference in the rate of HP eradication between both groups ( P 〉 0. 05 ). Conclusion The healing rate and total effective rate of the combined therapy with esomeprazole plus clarithromycin and amoxi- cillin are much better than that of the method with omeprazole plus clarithromycin and amoxicillin triple therapy with a relatively lower HP eradication rate.
作者 鲍良生 孔梅
出处 《中华全科医学》 2010年第6期715-716,共2页 Chinese Journal of General Practice
关键词 埃索关拉唑 幽门螺旋杆菌 消化性溃疡 Esomeprazole Helicobacter pylori Peptic ulcer
  • 相关文献

参考文献9

二级参考文献47

共引文献92

同被引文献33

  • 1杨萱,朱顺强.奥美拉唑与兰索拉唑治疗消化性溃疡的疗效观察[J].中国基层医药,2005,12(11):1609-1609. 被引量:4
  • 2李兆申,湛先保,许国铭.胃黏膜损伤与保护:基础与临床[M].第2版.上海科学技术出版社,2011.518-523.
  • 3刘晓光.奥美拉唑四联法治疗及预防消化性溃疡病复发的研究[J].检验医学与临床,2007,4(10):927-928. 被引量:1
  • 4Kamani F, Hessami R, Abrishami A. Benign duodenocollc fistula as a complication of peptic ulcer disease [ J ]. Gastroenterol Hepalol Bed Bench,2014,7( 1 ) :72 -75.
  • 5Cheng HC,Wu CT, Chang WL,et al. Double oral esomeprazule after a 3-day intravenons esomeprazole infusion reduces recurrent peptic nicer bleeding in high-risk patients: a randomised controlled study [J]. Gut,2014,63(12) :1864 - 1872.
  • 6Johnstone AS. Peptic Ulceration of the sophagus with partial thoracic stomach[J]. Br J Radiol,2014,16(192) :357 -361.
  • 7Lanas A ,Polo-Tomas M, Garcia-Rodriguez LA, et al. Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding:comparison of event rates in routineclinieal practice and a clinical trial [ J ]. Scand J Gastroentero1,2013,48 (3) :285 - 294.
  • 8HernOndez-Diaz S, Martin-Merino E, Garcia Rodrlguez LA. Risk of complications after a peptic ulcer diagnosis: effectiveness of proton pump inhibitors [ J]. Dig Dis Sci ,2013,58 (6) : 1653 - 1662.
  • 9Leontiadis GI, Molloy-Bland M, Moayyedi P, et al. Effecl of cnmor- bidity on mortality in patients with peplic ulcer bleeding:systematic review and meta-analysis [ J ]. Am J Gastroenterol, 2013,108 ( 3 ) : 331 - 345.
  • 10许同铭,钟捷质子泵抑制剂一基础与临床[M].上海:上海科技教育出版社,2004:21.

引证文献4

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部